# | Title | Journal | Year | Citations |
---|
1 | Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) | Autophagy | 2016 | 4,701 |
2 | Guidelines for the use and interpretation of assays for monitoring autophagy | Autophagy | 2012 | 3,122 |
3 | Ferroptosis: process and function | Cell Death and Differentiation | 2016 | 2,270 |
4 | The Beclin 1 network regulates autophagy and apoptosis | Cell Death and Differentiation | 2011 | 1,972 |
5 | Autophagy promotes ferroptosis by degradation of ferritin | Autophagy | 2016 | 1,318 |
6 | Activation of the p62‐Keap1‐NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells | Hepatology | 2016 | 1,263 |
7 | PAMPs and DAMPs: signal 0s that spur autophagy and immunity | Immunological Reviews | 2012 | 899 |
8 | Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells | Blood | 2004 | 868 |
9 | Endogenous HMGB1 regulates autophagy | Journal of Cell Biology | 2010 | 819 |
10 | Interleukin-17 promotes angiogenesis and tumor growth | Blood | 2003 | 743 |
11 | The grateful dead: damage‐associated molecular pattern molecules and reduction/oxidation regulate immunity | Immunological Reviews | 2007 | 565 |
12 | RAGE (Receptor for Advanced Glycation Endproducts), RAGE Ligands, and their role in Cancer and Inflammation | Journal of Translational Medicine | 2009 | 491 |
13 | Metallothionein‐1G facilitates sorafenib resistance through inhibition of ferroptosis | Hepatology | 2016 | 462 |
14 | HSPB1 as a novel regulator of ferroptotic cancer cell death | Oncogene | 2015 | 459 |
15 | Essential Role of Induced Nitric Oxide in the Initiation of the Inflammatory Response after Hemorrhagic Shock | Journal of Experimental Medicine | 1998 | 457 |
16 | High-mobility group box 1 and cancer | Biochimica Et Biophysica Acta - Gene Regulatory Mechanisms | 2010 | 442 |
17 | HMGB1 release and redox regulates autophagy and apoptosis in cancer cells | Oncogene | 2010 | 421 |
18 | High-Mobility Group Box 1, Oxidative Stress, and Disease | Antioxidants and Redox Signaling | 2011 | 420 |
19 | Multiple Drug Resistance in Cancer Revisited: The Cancer Stem Cell Hypothesis | Journal of Clinical Pharmacology | 2005 | 411 |
20 | HMGB1 in Cancer: Good, Bad, or Both? | Clinical Cancer Research | 2013 | 399 |
21 | The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents | Molecular and Cellular Oncology | 2015 | 301 |
22 | Cancer and Inflammation: Promise for Biologic Therapy | Journal of Immunotherapy | 2010 | 293 |
23 | The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival | Cell Death and Differentiation | 2010 | 281 |
24 | High-Mobility Group Box 1 Is Essential for Mitochondrial Quality Control | Cell Metabolism | 2011 | 266 |
25 | Posttranslational modification of autophagy-related proteins in macroautophagy | Autophagy | 2015 | 264 |
26 | IL-18–induced CD83+CCR7+ NK helper cells | Journal of Experimental Medicine | 2005 | 260 |
27 | Oncolytic viruses as therapeutic cancer vaccines | Molecular Cancer | 2013 | 252 |
28 | p53/HMGB1 Complexes Regulate Autophagy and Apoptosis | Cancer Research | 2012 | 220 |
29 | HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells | Leukemia | 2011 | 218 |
30 | Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor Immunity | Frontiers in Oncology | 2014 | 216 |
31 | Oxidative stress-mediated HMGB1 biology | Frontiers in Physiology | 2015 | 210 |
32 | The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergetics | Oncogene | 2014 | 192 |
33 | Hypoxia induced HMGB1 and mitochondrial DNA interactions mediate tumor growth in hepatocellular carcinoma through Toll-like receptor 9 | Journal of Hepatology | 2015 | 189 |
34 | HMGB1: A novel Beclin 1-binding protein active in autophagy | Autophagy | 2010 | 183 |
35 | High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells | Proceedings of the National Academy of Sciences of the United States of America | 2002 | 170 |
36 | Complementary Dendritic Cell–activating Function of CD8+ and CD4+ T Cells | Journal of Experimental Medicine | 2002 | 167 |
37 | Induction of systemic and therapeutic antitumor immunity using intratumoral injection of dendritic cells genetically modified to express interleukin 12 | Cancer Research | 1999 | 160 |
38 | Interleukin-10 promotes the maintenance of antitumor CD8+ T-cell effector function in situ | Blood | 2001 | 159 |
39 | Differential Antitumor Effects of Administration of Recombinant IL-18 or Recombinant IL-12 Are Mediated Primarily by Fas-Fas Ligand- and Perforin-Induced Tumor Apoptosis, Respectively | Journal of Immunology | 1999 | 149 |
40 | Role of polymorphic Fc gamma receptor IIIa and EGFR expression level in cetuximab mediated, NK cell dependent in vitro cytotoxicity of head and neck squamous cell carcinoma cells | Cancer Immunology, Immunotherapy | 2009 | 148 |
41 | T-cell Engager-armed Oncolytic Vaccinia Virus Significantly Enhances Antitumor Therapy | Molecular Therapy | 2014 | 140 |
42 | The expression of the receptor for advanced glycation endproducts (RAGE) is permissive for early pancreatic neoplasia | Proceedings of the National Academy of Sciences of the United States of America | 2012 | 139 |
43 | Eat-Me: Autophagy, Phagocytosis, and Reactive Oxygen Species Signaling | Antioxidants and Redox Signaling | 2013 | 138 |
44 | Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively | Journal of Immunology | 1999 | 134 |
45 | Inhibiting Systemic Autophagy during Interleukin 2 Immunotherapy Promotes Long-term Tumor Regression | Cancer Research | 2012 | 133 |
46 | A novel bulk-culture method for generating mature dendritic cells from mouse bone marrow cells | Journal of Immunological Methods | 2002 | 128 |
47 | EphA2 as a Glioma-Associated Antigen: A Novel Target for Glioma Vaccines | Neoplasia | 2005 | 126 |
48 | Cell-Mediated Autophagy Promotes Cancer Cell Survival | Cancer Research | 2012 | 122 |
49 | Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-alpha | Journal of Immunology | 1998 | 120 |
50 | Genetically modified bone marrow-derived dendritic cells expressing tumor-associated viral or “self” antigens induce antitumor immunityin vivo | European Journal of Immunology | 1997 | 119 |